Nine Cyclists with Type 1 Diabetes Join Team Novo's Professional Roster in 2027 Season
Nine Cyclists Set to Join Team Novo in 2027
In an exciting development for the cycling community, Team Novo has announced that nine riders living with type 1 diabetes will turn professional, marking a significant milestone in the sport. These athletes have successfully advanced through Team Novo's specialized pathway and will officially kick off their professional careers in 2027. This move not only showcases talent but also underscores a commitment to inclusivity in professional sports.
Team Novo, which is pioneering as the world’s first professional cycling team composed entirely of athletes with diabetes, has curated a roster that reflects both diversity and skill. In total, the team will feature 22 riders hailing from ten different countries for its upcoming 15th season. As Phil Southerland, CEO and co-founder of Team Novo, stated, "We built the Team Novo talent pipeline so young riders living with type 1 diabetes have a route to the pro peloton."
Among the newly signed riders are four newcomers from the Talent Identification Program: Mathys Lafage from France, Amos Scott Bouris from Canada, Tyler Tomkinson from Australia, and Adam Žitný from the Czech Republic. Additionally, five riders are stepping up from the development team: Jeffe Beets (Belgium), Oliver Clements (Australia), Marco Grittner (Germany), Richard Rundva (Estonia), and Hayden Stevens (Australia). This diverse mix truly highlights the effectiveness of Team Novo's programs for nurturing young talent.
A Network of Support
Southerland emphasizes that these achievements are not individual ones, stating, "None of them got here alone. There are families, coaches, teammates, and healthcare teams behind everyone." The support system surrounding these athletes fosters an environment where dreams are reachable, even for those grappling with the challenges of diabetes.
The importance of role models cannot be overstated, as Martin Nordmark from Novo, the Danish pharmaceutical company and team sponsor, points out. He remarked, "Seeing nine riders living with type 1 diabetes earn their first professional contracts shows why Novo continues to support this team. Their progress reflects the daily commitment and support behind lasting health."
In 2026, Team Novo already impressed spectators and stakeholders alike, with riders clinching two podium finishes and earning jerseys on numerous occasions. Noteworthy highlights from the season included Declan Irvine's second-place finish at Unbound Gravel and David Lozano’s success at the Philadelphia Cycling Classic.
Advice from Seasoned Riders
Regarding the new entrants, seasoned rider David Lozano, who has been with Team Novo since its inception, provided some friendly advice: “Listen to the people around you, because nobody does this alone. With diabetes, every day teaches you something. Be patient, and enjoy it.” This wisdom underlines the resilience and perseverance that characterize athletes in this unique sport.
As Team Novo gears up for the 2027 season, they are ready to make strides in cycling while continuing to foster a culture of support and camaraderie. Potential new candidates looking to join the ranks of Team Novo can find more information about their Talent ID program through their official site.
In conclusion, the integration of these nine professional cyclists into Team Novo is a celebratory moment—not just for the individuals involved but for all athletes with diabetes who see their aspirations realized on the competitive stage. With ongoing support, encouragement, and visibility, Team Novo is paving the way for a future where diabetes does not hinder dreams but propels them forward.